| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA739192 | F | Minimum effective concentration required for more than 1 IU/mL induction of IFN using mice spleen cells | Mus musculus | 48 | organism-based format | Scientific Literature | ||
| 2. | ALA739730 | F | Minimum effective dose required for more than 100 IU/mL induction of IFN using mice after peroral administration. | Mus musculus | 26 | organism-based format | Scientific Literature | ||
| 3. | ALA830466 | F | Minimum effective concentration required to induce interferon (IFN) production in human peripheral blood mononuclear cells (hPBMC) | Homo sapiens | 35 | assay format | Scientific Literature | ||
| 4. | ALA1794345 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 170,142 | organism-based format | PubChem BioAssays | ||
| 5. | ALA2114843 | F | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | Homo sapiens | 68,424 | assay format | PubChem BioAssays | ||
| 6. | ALA2114780 | F | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | Homo sapiens | 58,727 | cell-based format | PubChem BioAssays | ||
| 7. | ALA1909163 | B | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | tissue-based format | DrugMatrix | ||
| 8. | ALA1909164 | B | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | cell membrane format | DrugMatrix | |||
| 9. | ALA1909165 | B | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | tissue-based format | DrugMatrix | ||
| 10. | ALA1909166 | B | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
| 11. | ALA1909167 | B | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
| 12. | ALA1909168 | B | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
| 13. | ALA1909169 | B | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | 871 | cell-based format | DrugMatrix | |||
| 14. | ALA1909170 | B | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
| 15. | ALA1909171 | B | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
| 16. | ALA1909172 | B | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
| 17. | ALA1909173 | B | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
| 18. | ALA1909174 | B | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
| 19. | ALA1909175 | B | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | 871 | cell membrane format | DrugMatrix | |||
| 20. | ALA1909176 | B | DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) | 871 | cell membrane format | DrugMatrix |
The page will load shortly, Thanks for your patience!